[Chronic abdominal ischemia: clinical manifestations, diagnostic potential and treatment policy].
OBJECTIVE
To define variants of clinical course of chronic abdominal ischemia (CAI) and treatment policy depending on functional class of the disease.


METHODS
The examination of 236 patients with CAI included clinicolaboratory, endoscopic, x-ray and ultrasonic investigations, ultrasonic dopplerography, x-ray contrast aortoarteriography, histological analysis of gastric, duodenal and colon mucosa biopsies.


RESULTS
6 variants of CAI clinical course were distinguished. Most frequent CAI manifestations were erosive-ulcerative gastroduodenal lesions, primarily in men, which combined with ischemic heart disease and atherosclerosis of lower limb vessels. Women often presented with pseudopancreatic variant which was associated with hypertension and dyslipoproteinemia. By severity of clinical symptoms, 3 functional classes of the diseases were recognized. They are decisive for the treatment policy. Biopsy specimens of the mucosa exhibited dystrophy in weak inflammation.


CONCLUSIONS
Today's diagnostic techniques and recognition of functional classes of the disease contribute to correct decision on the treatment policy.
Loginov
A S
AS
Zvenigorodskaia
L A
LA
Samsonova
N G
NG
Toporkov
A S
AS
Kuznetsov
M R
MR
Bychkov
S G
SG
D000005:Abdomen / Q000098:blood supply* / Q000000981:diagnostic imaging; D000293:Adolescent; D000328:Adult; D000368:Aged; D000792:Angiography; D000975:Antioxidants / Q000627:therapeutic use*; D001706:Biopsy; D001783:Blood Flow Velocity; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004032:Diet / Q000379:methods*; D005260:Female; D006801:Humans; D007422:Intestines / Q000098:blood supply / Q000000981:diagnostic imaging / Q000473:pathology; D007511:Ischemia / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011860:Radiography, Abdominal; D012189:Retrospective Studies; D018615:Ultrasonography, Doppler, Color; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000975:Antioxidants; D014665:Vasodilator Agents